Your browser doesn't support javascript.
loading
Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease.
Beltrán, Belén; Iborra, Marisa; Sáez-González, Esteban; Marqués-Miñana, Maria R; Moret, Inés; Cerrillo, Elena; Tortosa, Luis; Bastida, Guillermo; Hinojosa, Joaquín; Poveda-Andrés, Jose Luis; Nos, Pilar.
Afiliación
  • Beltrán B; Department of Gastroenterology, Inflammatory Bowel Disease Unit, La Fe University and Polytechnic Hospital, Valencia, Spain.
  • Iborra M; Inflammatory Bowel Disease Research Group, Medical Research Institute Hospital La Fe (IIS La Fe), Valencia, Spain.
  • Sáez-González E; Networked Biomedical Research Center for Hepatic and Digestive Diseases (CIBEREHD), Madrid, Spain.
  • Marqués-Miñana MR; Department of Gastroenterology, Inflammatory Bowel Disease Unit, La Fe University and Polytechnic Hospital, Valencia, Spain.
  • Moret I; Inflammatory Bowel Disease Research Group, Medical Research Institute Hospital La Fe (IIS La Fe), Valencia, Spain.
  • Cerrillo E; Networked Biomedical Research Center for Hepatic and Digestive Diseases (CIBEREHD), Madrid, Spain.
  • Tortosa L; Department of Gastroenterology, Inflammatory Bowel Disease Unit, La Fe University and Polytechnic Hospital, Valencia, Spainesteban.digestivo@gmail.com.
  • Bastida G; Inflammatory Bowel Disease Research Group, Medical Research Institute Hospital La Fe (IIS La Fe), Valencia, Spainesteban.digestivo@gmail.com.
  • Hinojosa J; Pharmacy Department, Medication Clinical Area, La Fe University and Polytechnic Hospital, Valencia, Spain.
  • Poveda-Andrés JL; Department of Gastroenterology, Inflammatory Bowel Disease Unit, La Fe University and Polytechnic Hospital, Valencia, Spain.
  • Nos P; Inflammatory Bowel Disease Research Group, Medical Research Institute Hospital La Fe (IIS La Fe), Valencia, Spain.
Dig Dis ; 37(2): 108-115, 2019.
Article en En | MEDLINE | ID: mdl-30149385

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Complejo de Antígeno L1 de Leucocito / Heces / Infliximab Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Dig Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2019 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Complejo de Antígeno L1 de Leucocito / Heces / Infliximab Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Dig Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2019 Tipo del documento: Article País de afiliación: España